Table 1.
Characteristics of African-American ovarian cancer survivors by recreational physical activity (MET-hours/week) before diagnosis (n = 264)
| Inactive (0 MET-hours/week)a
n = 90 |
> 0–9 MET-hours/week n = 94 |
> 9 MET-hours/week n = 80 |
p value | ||||
|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | ||
|
| |||||||
| Mean age at diagnosis (years) (SD) | 58.9 | (10.2) | 57.8 | (9.6) | 57.4 | (11.1) | 0.72 |
| Median age at diagnosis (years) | 58.0 | 56.0 | 58.5 | ||||
| Region | 0.35 | ||||||
| South and mid-Atlantic | 48 | (53.3) | 60 | (63.8) | 41 | (51.3) | |
| South central | 28 | (31.1) | 25 | (26.6) | 24 | (30.0) | |
| Midwest | 14 | (15.6) | 9 | (9.6) | 15 | (18.8) | |
| Education | 0.02 | ||||||
| High school or less | 51 | (56.7) | 38 | (40.4) | 28 | (35.0) | |
| Some post-high school training | 21 | (23.3) | 26 | (27.7) | 19 | (23.8) | |
| College or graduate degree | 18 | (20.0) | 30 | (31.9) | 33 | (41.3) | |
| Family income | 0.41 | ||||||
| < $25,000 | 45 | (50.0) | 39 | (41.5) | 33 | (41.3) | |
| ≥ $25,000 | 45 | (50.0) | 55 | (58.5) | 47 | (58.8) | |
| Number of comorbid conditionsb | 0.11 | ||||||
| 0 | 25 | (27.8) | 39 | (41.5) | 38 | (47.5) | |
| 1 | 23 | (25.6) | 21 | (22.3) | 15 | (18.8) | |
| 2+ | 42 | (46.7) | 34 | (36.2) | 27 | (33.8) | |
| Body Mass Index (BMI) (kg/m2) | 0.42 | ||||||
| <25 (underweight or normal weight) | 11 | (12.2) | 13 | (13.8) | 18 | (22.5) | |
| 25–29.9 (overweight) | 24 | (26.7) | 26 | (27.7) | 20 | (25.0) | |
| 30+ (obese) | 55 | (61.1) | 55 | (58.5) | 42 | (52.5) | |
| Parity (number of live births) | 0.37 | ||||||
| 0 | 11 | (12.2) | 19 | (20.2) | 20 | (25.0) | |
| 1 | 13 | (14.4) | 18 | (19.2) | 10 | (12.5) | |
| 2 | 25 | (27.8) | 21 | (22.3) | 20 | (25.0) | |
| 3+ | 41 | (45.6) | 36 | (38.3) | 30 | (37.5) | |
| Family history of breast or ovarian cancer | 0.14 | ||||||
| No | 71 | (78.9) | 63 | (67.0) | 54 | (67.5) | |
| Yes | 19 | (21.1) | 31 | (33.0) | 26 | (32.5) | |
| Menopausal status | 0.49 | ||||||
| Premenopausal | 20 | (22.2) | 28 | (29.8) | 20 | (25.0) | |
| Postmenopausal | 70 | (77.8) | 66 | (70.2) | 60 | (75.0) | |
| Smoking status | 0.31 | ||||||
| Never | 49 | (54.4) | 60 | (63.8) | 43 | (53.8) | |
| Ever | 41 | (45.6) | 34 | (36.2) | 37 | (46.3) | |
| Occupational physical activity | 0.40 | ||||||
| Mainly sitting | 16 | (17.8) | 16 | (17.0) | 13 | (16.3) | |
| Mainly standing or walking | 18 | (20.0) | 15 | (16.0) | 22 | (27.5) | |
| Mainly active | 10 | (11.1) | 18 | (19.2) | 14 | (17.5) | |
| Do not work outside the home | 46 | (51.1) | 45 | (47.9) | 31 | (38.8) | |
| Stage | 0.79 | ||||||
| I–II | 30 | (33.3) | 32 | (34.0) | 32 | (40.0) | |
| III–IV | 55 | (61.1) | 58 | (61.7) | 46 | (57.5) | |
| Unstaged | 5 | (5.6) | 4 | (4.3) | 2 | (2.5) | |
| Histology | 0.93 | ||||||
| Serous | 63 | (70.0) | 65 | (69.2) | 54 | (67.5) | |
| Mucinous | 1 | (1.1) | 7 | (7.5) | 2 | (2.5) | |
| Endometrioid | 15 | (16.7) | 12 | (12.8) | 10 | (12.5) | |
| Clear cell | 2 | (2.2) | 5 | (5.3) | 4 | (5.0) | |
| Other | 7 | (7.8) | 5 | (5.3) | 8 | (10.0) | |
| Missing | 2 | (2.2) | 0 | (0.0) | 2 | (2.5) | |
| Residual disease | 0.09 | ||||||
| Optimal debulking | 31 | (34.4) | 39 | (41.5) | 43 | (53.8) | |
| Suboptimal debulking | 20 | (22.2) | 14 | (14.9) | 11 | (13.8) | |
| Missing residual disease | 39 | (43.3) | 41 | (43.6) | 26 | (32.5) | |
a
Metabolic equivalent of task (MET)-hours/week
b
Number of comorbid conditions was determined using a modified Charlson comorbidity index [22]
cp value is for serous versus non-serous cases due to small numbers of non-serous histotypes